MON-645 Association of Baseline Cardio-Metabolic Parameters on the Treatment Effects of Empagliflozin When Added to Metformin in Patients with T2D

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are commonly used as 2(nd)-line therapy after metformin (MET) in patients with type 2 diabetes (T2D), and are now recommended in those with co-existing cardiovascular (CV) and/or chronic kidney disease (CKD). A better understanding of their clinica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Inzucchi, Silvio E, Davies, Melanie, Khunti, Kamlesh, Trivedi, Prabhav, George, Jyothis T, Zwiener, Isabella, Johansen, Odd Erik, Sattar, Naveed
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Diabetes Mellitus and Glucose Metabolism
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209010/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.414
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados